Riskpilot← Back to searchSign inGet full accessClase Medical AB
ABActiveOrg 5592574783Gröndalsgatan 11 AGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2024
SEK 157K
-71% vs 2023
EBITDA margin
53.0%
-82% vs 2023
Equity ratio
94.7%
Financial strength
Net profit 2024
SEK 65K
-82% vs 2023
| Revenue | SEK 157K | -71% |
| EBITDA | SEK 83K | -82% |
| Net profit | SEK 65K | -82% |
| Total assets | SEK 601K | -41% |
| Equity | SEK 569K | -29% |
| Employees | 0 | — |
Legal name
Clase Medical AB
Org number
5592574783
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 maj 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård inom primärvård, öppenvård, slutenvård samt idrottsverksamhet. Bolaget ska bedriva verksamhet inom kosmetiska behandlingar och utföra kosmetiska ingrepp. Bedriva undervisningsverksamhet inom hälso- och och sjukvård. Bolaget ska äga, förvalta och handla med värdepapper.
Address
Gröndalsgatan 11 A
Email
ludvigclase@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 93 | 321 | 268 | 538 | 157 |
| Staff expenses | — | — | −11 | −9 | −0 |
| EBITDA | 25 | 280 | 212 | 466 | 83 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 25 | 280 | 212 | 466 | 83 |
| Net financials | — | — | 0 | −0 | −1 |
| Profit before tax | 24 | 281 | 212 | 466 | 82 |
| Tax | −5 | −58 | −44 | −96 | −17 |
| Net profit | 19 | 223 | 168 | 369 | 65 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 58 | 403 | 609 | 1 011 | 601 |
| Equity | 44 | 267 | 435 | 804 | 569 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 13 | 137 | 174 | 207 | 32 |
| Total debt | 13 | 137 | 174 | 207 | 32 |
EBITDA margin
53.0%
This company
15.8%
Market median
+235% vs market
20202024
Equity ratio
94.7%
This company
38.2%
Market median
+148% vs market
20202024
Return on equity
11.4%
This company
18.4%
Market median
+38% vs market
20202024
Net profit margin
41.4%
This company
8.1%
Market median
+411% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-05-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Clase Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ludvig Anders Bertil Algemark Clase | Board of Directors | 0 companies |
| Charlotte Patricia Clase | Deputy Board Member | 0 companies |